Abstract

Purpose: To estimate the prevalence and pattern of ocular morbidity among patients attending the leprosy clinic in Siliguri, West Bengal, and identify the risk factors associated with it, if any. Methods: It was a clinic-based observational study with a cross-sectional design conducted at Leprosy Clinic, Siliguri, West Bengal among leprosy patients for 1 year from August 2022 to July 2023. Leprosy patients who had completed multi-drug therapy and consented to the study were enrolled. Convenience sampling was performed and the sample size was 117. After a detailed ophthalmic evaluation, the socio-demographic profile of participants and their ocular morbidities were documented and analyzed. A Chi-square test was performed to identify the factors associated with leprosy complications. P value < 0.05 was considered statistically significant. Results: Overall ocular morbidity for any eye observed was 58.1%. Major findings were cataract (35.9%), aphakia (11.1%), diminished corneal sensation (7.7%), lagophthalmos (7.7%), mild corneal opacity (5.2%), chronic iritis (3.4%), and impaired lid closure (2.6%). Ectropion was present in 2.6% bilaterally. According to the World Health Organization (WHO) criteria for blindness, 11.1% of patients were blind in both eyes. Ocular complications were significantly associated with the respondent’s age, duration of disease, classification of disease, and decreased vision. Conclusions: The present study shows a significant rate of ocular complications and blindness among leprosy patients. Lid abnormalities, corneal abnormalities, and cataracts were the commonly encountered ocular morbidities among treated leprosy patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.